Scientific Industries Reports Financial Results for Second Quarter 2023
Benchtop Lab Equipment Revenue Up Led by Torbal Division's 48% Increase - Bioprocessing Revenue Up 41%BOHEMIA, NY / ACCESSWIRE /...
Month: August 2023
Empatho Holdings Inc. Announces Shares for Debt Settlement
Toronto, Ontario--(Newsfile Corp. - August 14, 2023) - Empatho Holdings Inc. (CSE: EMPH) (formerly, Shane Resources Ltd.) ("Empatho" or the...
Assisted Home Health & Hospice Honors Veteran Roger Dawson With Pinning Ceremony
We Honor VeteransTHOUSAND OAKS, CA / ACCESSWIRE / August 14, 2023 / Assisted Hospice Care in Phoenix, Arizona, celebrated the...
CBD of Denver (CBDD) Expands on the Plans for Luxora Operations and Initiates Strategic Plans for Both Subsidiaries
Denver, Colorado--(Newsfile Corp. - August 14, 2023) - CBD of Denver, Inc. (OTC Pink: CBDD) a leading innovation company, announces...
Zion Healing Inc. Announces $25 Million Private Placement to Fund Innovative Veterans Initiative
SAINT GEORGE, UT / ACCESSWIRE / August 14, 2023 / Zion Healing Inc. and its subsidiary, Zion Healing Development Company,...
Sound Physicians & AdventHealth Expand Partnership
Hospital medicine staff to care for patients at AdventHealth's newest Flagler County hospitalTACOMA, WA / ACCESSWIRE / August 14, 2023...
Hemostemix Announces Arbitration Award of CAD $315,684 Plus Private Placement
Calgary, Alberta--(Newsfile Corp. - August 14, 2023) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) is pleased to announce...
Virginia Commonwealth University to Offer 23 New Programs with MedCerts Partnership
Adult learners gain access to in-demand online certification programs in the healthcare industryRICHMOND, Va.--(BUSINESS WIRE)--#StrideLearn--MedCerts, the innovation leader in online...
GE HealthCare Receives FDA Clearance for Portrait Mobile, A First-Of-Its-Kind, Wireless Monitoring Solution Aiding Early Detection of Patient Deterioration
GE HealthCare’s smart phone-sized Portrait Mobile frees the patient from the hospital bed while providing continuous monitoring of vital signs,...
Health Karma(R) Group Announces Partnership with OXIO Health, Inc. to offer access to Centralized Personal Health Record using Artificial Intelligence
FORT LAUDERDALE, FL / ACCESSWIRE / August 14, 2023 / MediXall Group Inc. (OTC PINK:MDXL) ("MediXall"), an innovative virtual health...
Curated Mental Health Expands Services to New Location in Williamsburg
BROOKLYN, NY / ACCESSWIRE / August 14, 2023 / Curated Mental Health proudly announces its expansion to a new location...
Bio-Conscious Announces Breakthrough in Forecasting Nocturnal Hypoglycemia Events Using Machine Learning (ML) Techniques and CGM data.
VANCOUVER, BC / ACCESSWIRE / August 14, 2023 / Bio Conscious Technologies Inc. ("Bio Conscious Technologies" or the "Company"), a...
CNS Pharmaceuticals (NASDAQ: CNSP) Presents Updated Results from On-Going Potentially Pivotal Study of Berubicin in Adult Patients with Recurrent GBM (WHO Grade IV) After Failure of Standard First Line Therapy
Data presented at the 2023 SNO/ASCO CNS Cancer ConferenceBerubicin currently being evaluated in an ongoing potentially pivotal study for the...
Stemtech Announces China Market Expansion
Stemtech Unveils Bold Vision ‘Grand China Market Plan' to Supercharge China's Thriving Health and Wellness Landscape Amidst $ 683 Billion...
Biotricity to Host First Quarter Fiscal Year 2024 Financial Results and Business Update Call on August 15th
REDWOOD CITY, CA / ACCESSWIRE / August 14, 2023 / Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a Technology-as-a-Service (TaaS)...
Halberd-Mississippi State University (MSU) Testing of TBI Nasal Spray Progresses
Scientific Paper Presented at Research SymposiumJACKSON CENTER, PA / ACCESSWIRE / August 14, 2023 / Halberd Corporation's (OTC PINK:HALB) Traumatic...
Jaguar Health Reports Second Quarter 2023 Financial Results
Net revenue increased 36% in Q2 2023 versus Q1 2023Top line results expected late October 2023 for company's phase 3...
Sonnet BioTherapeutics Provides Fiscal Year 2023 Third Quarter Business and Earnings Update
Combination study of SON-1010 with Roche's atezolizumab (Tecentriq®) has been initiated in AustraliaFirst SON-1010 Phase 1 study has been completed...
CNS Pharmaceuticals Reports Second Quarter 2023 Financial Results and Reiterates Upcoming Milestones
Continued rapid pace of enrollment with ~75% of expected patients now enrolled in ongoing potentially pivotal study evaluating Berubicin for...
LFTD Partners Inc. Reports $0.11 Basic EPS in Q2 2023
JACKSONVILLE, FL / ACCESSWIRE / August 14, 2023 / LFTD Partners Inc. ("LFTD Partners" or the "Company") (OTCQB:LIFD), the corporate...